Pluri Inc. (PLUR) vs Palatin Technologies, Inc. (PTN)

Pluri Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Pluri Inc. and Palatin Technologies, Inc. are of similar size ($11.9M and $11.6M). Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −24.0%. Palatin Technologies, Inc. has the higher net margin (−63.5% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 17 metrics below, Palatin Technologies, Inc. leads on 13 and Pluri Inc. on 4.

Valuation

Metric PLUR PTN Biotechnology median
P/E n/m n/m 8.50
P/S 8.92 1.29 9.71
P/B n/m 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 28.99 0.73 9.21
Earnings yield (263.44%) (49.33%) (33.15%)
Free cash flow yield (222.94%) (79.85%) (25.50%)

Profitability

Metric PLUR PTN Biotechnology median
Gross margin 44.59% 100.00% 65.16%
Operating margin (2,454.53%) (65.74%) 0.00%
Net margin (2,344.59%) (63.54%) 0.00%
Free cash flow margin (1,988.48%) (103.07%) 0.00%
Return on equity 260.35% (877.60%) (56.36%)
Return on assets (74.95%) (142.11%) (48.04%)
Return on invested capital (526.92%) 0.00% 0.00%

Growth

Metric PLUR PTN Biotechnology median
Revenue growth (TTM) (23.95%) 110.89% 6.02%
EPS growth (last fiscal year) 31.46% 90.79% 30.26%
Revenue growth, 5-year CAGR 113.32% 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLUR PTN Biotechnology median
Debt to equity (1.62) 0.00 0.00
Current ratio 0.27 4.61 4.72
Net debt to EBITDA (0.83) 0.87 0.96

Dividend

Metric PLUR PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PLUR PTN Biotechnology median
Market cap 11.86m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack